Thursday, December 4, 2008 - 3:25PM EST

Clinical Trials

41. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.

Author
Winner P; Cady RK; Ruoff GE; Frishberg BM; Alexander WJ; Zhang Y; Kori SH; Lener SE;
Institution
Palm Beach Headache Center, 4631 N Congress Ave, Suite 200, West Palm Beach, FL 33407, USA. eneuro@aol.com
Journal
Mayo Clin Proc. 2007 Jan;82(1):61-8.
Abstract URL
Click here to view abstract

42. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).

Author
Gupta P; Singh S; Goyal V; Shukla G; Behari M;
Institution
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Journal
Headache. 2007 Mar;47(3):402-12.
Abstract URL
Click here to view abstract

43. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial.

Author
John PJ; Sharma N; Sharma CM; Kankane A;
Institution
Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, India.
Journal
Headache. 2007 May;47(5):654-61.
Abstract URL
Click here to view abstract

44. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.

Author
Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS;
Institution
Jefferson Headache Center, Philadelphia, PA 19107, USA.
Journal
Headache. 2007 May;47(5):673-82.
Abstract URL
Click here to view abstract

45. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.

Author
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S;
Institution
Mercy Health Research and Ryan Headache Center, St. Louis, MO 63141, USA.
Journal
Headache. 2007 May;47(5):683-92.
Abstract URL
Click here to view abstract

46. Efficacy of lisinopril in migraine prophylaxis--an open label study.

Author
Schuh-Hofer S; Flach U; Meisel A; Israel H; Reuter U; Arnold G;
Institution
Department of Neurology, Universitatsklinikum Tuebingen, Tuebingen, Germany.sigrid.schuh-hofer@gmx.net
Journal
Eur J Neurol. 2007 Jun;14(6):701-3.
Abstract URL
Click here to view abstract

47. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.

Author
Silberstein SD; Young WB; Hopkins MM; Gebeline-Myers C; Bradley KC;
Institution
Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Journal
Headache. 2007 Jun;47(6):878-85.
Abstract URL
Click here to view abstract

48. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.

Author
Brandes JL; Smith T; Diamond M; Ames MH;
Institution
Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Journal
Headache. 2007 Jun;47(6):886-94.
Abstract URL
Click here to view abstract

49. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.

Author
Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE;
Institution
Nashville Neuroscience Group, Nashville, Tenn 37203, USA. jbrandes@nashvilleneuroscience.com
Journal
JAMA. 2007 Apr 4;297(13):1443-54.
Abstract URL
Click here to view abstract

50. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.

Author
Relja M; Poole AC; Schoenen J; Pascual J; Lei X; Thompson C;
Institution
Department of Neurology, Medical School University of Zagreb, Zagreb, Croatia. mrelja@mef.hr
Journal
Cephalalgia. 2007 Jun;27(6):492-503. Epub 2007 Apr 11.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6